Alzheimer's Disease

The Model Organism Development and Evaluation for Late-Onset Alzheimer’s Disease (MODEL-AD) consortium is developing the next generation of laboratory models used by scientists throughout the United States to study genetic contributors to Alzheimer’s disease and test potential treatments. MODEL-AD animal models represent human Alzheimer’s disease more closely than existing mouse models and accelerate the development of effective therapies for the disease.

The federal government has designated IU School of Medicine as the national site to collect blood, DNA, tissue, spinal fluid and other samples from tens of thousands of people with Alzheimer’s disease across the country. The National Centralized Repository for Alzheimer’s Disease and Related Dementias (NCRAD) is a central biobank in the United States that enables scientists from around the world to access critically important biological samples for new and ongoing research.

At the forefront of Alzheimer’s disease research for more than 30 years, the Indiana Alzheimer's Disease Research Center is one of only 33 centers in the United States solely committed to Alzheimer’s research. This multidisciplinary program works to translate research advances into improved diagnosis and care for people with Alzheimer’s disease. The center offers resources and information for patients, caregivers and the broader community.